Trials / Recruiting
RecruitingNCT05865470
Age-dependent Effects of Smoked and Oral Delta-9-THC
Sex- and AGE-dependent Effects of Smoked and Oral Delta-9-THC
- Status
- Recruiting
- Phase
- Phase 1
- Study type
- Interventional
- Enrollment
- 103 (estimated)
- Sponsor
- University of California, Los Angeles · Academic / Other
- Sex
- All
- Age
- 18 Years – 65 Years
- Healthy volunteers
- Accepted
Summary
This study will assess the age-dependent effects of smoked and oral THC on abuse liability, intoxication, analgesia and impairment as a function of age.
Detailed description
The overall objective of this placebo-controlled, outpatient study is to compare the dose-dependent effects of smoked and oral THC on analgesia and endpoints directly related to adverse consequences of use including abuse liability, intoxication, and impairment as a function of age and sex.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Cannabis | smoked cannabis |
| DRUG | Dronabinol | Oral delta-9-THC |
| DRUG | Smoked Placebo | Placebo Cannabis |
| DRUG | Oral Placebo | Oral Placebo |
Timeline
- Start date
- 2025-04-30
- Primary completion
- 2028-10-15
- Completion
- 2029-10-15
- First posted
- 2023-05-18
- Last updated
- 2026-01-07
Locations
1 site across 1 country: United States
Regulatory
- FDA-regulated drug study
Source: ClinicalTrials.gov record NCT05865470. Inclusion in this directory is not an endorsement.